Isn’t it amazing when we completely eliminate a cancer and never have it recur? For the first time, there has been a success in the fight against cervical cancer reports lead researcher, Dr. Christian Hinrichs from the U.S. National Cancer Institute. Quite simply, a patient’s own immune system is used to attack the cancer. Most cervical cancers are caused by the human papillomavirus (HPV), which changes healthy cells into tumor cells (t-cells). Immune cells from the tumor are collected, grown in the lab and then put back in the body to naturally fight the cancer.
Download .pdf: Click Here
Dr. Marianne Legato, Professor Emerita of Clinical Medicine at Columbia University is an internationally known academic physician, author, lecturer, and specialist in gender-specific medicine. She is founding member of the International Society for Gender Medicine and also the founder and director of The Partnership for Gender-Specific Medicine at Columbia University and its next iteration, The Foundation for Gender-Specific Medicine. These enterprises are the first collaborations between academic medicine and the private sector focused solely on gender-specific medicine: the science of how normal human biology differs between men and women and of how the diagnosis and treatment of disease differs as a function of gender and sex. Her ground breaking textbook on Gender-and Sex Specific Medicine has been published in 2017 in the 3rd edition.
She has published extensively on Gender and Sex Specific Medicine, both scientifically and for the lay public. She is also the founding editor of the journal Gender Medicine, and the Journal Gender and Genome, published for the scientific community. In 1992, Dr. Legato won the American Heart Association’s Blakeslee Award for the best book written for the lay public on cardiovascular disease. She is a practicing internist in New York City and has been listed each year in New York Magazine’s “Best Doctors” since the feature’s inception in 1993.
